How Simard was paid
$6.2M in total for 2024, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Other | Total |
|---|---|---|---|---|
| John SimardPresident & Chief Executive Officer | $1,205,083 | $5,030,000 | $10,498 | $6,245,581 |
| Sushma Shivaswamy, Ph.D.Chief Scientific Officer | $450,000 | $197,047 | $10,498 | $657,572 |
| Angela HuDirector of Finance | $200,000 | $80,000 | $5,419 | $285,419 |
What changed and why
- $6.2M$6,245,581 CEO total compensation in 2024, up from $5,556,481 in 2023.
- $5M$5,030,000 discretionary performance bonus drove most of the CEO’s 2024 compensation.
- 2024 option awards were shown as dashes for all three named executives.
- $101K62:1 CEO-to-median-employee pay ratio, with median employee compensation of $100,800.
- 35%35% maximum annual incentive cash payment applies to the CEO’s $1,250,000 current base salary.
- $658K$657,572 and $285,419 were total compensation for the other two named executives.
Other XBiotech proxy statements
- 2026 proxy statement
Sushma Shivaswamy, Ph.D. paid $570,992 (-13% on the year), pay ratio 345:1.
Filed Oct 02, 2026
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.